June 30, 2021 -- Twist Bioscience has acquired next-generation sequencing library preparation developer iGenomX for $35 million. The deal gives Twist a leg up in the shift from genotyping with static microarray platforms to using sequencing workflows.
IGenomX's sequencing library maximizes lab capacity for numerous applications, including the microbiome, synthetic biology, agrigenomics, and population genetics. The acquisition expands Twist's next-generation sequencing capabilities into new markets, while also accelerating the conversion to genotyping by sequencing workflows.
The total purchase consideration was $35 million, including a $500,000 cash payment and $29.5 million in Twist stock. Additionally, it included a contingency payment of $5 million in Twist shares upon completion of meeting specific milestones.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
